Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 1 regulatory subunit 3A (PPP1R3A) is a muscle-specific regulatory subunit of protein phosphatase 1 (PP1) that targets PP1 to glycogen particles in skeletal muscle and heart, enabling dephosphorylation of key enzymes involved in glycogen metabolism such as glycogen synthase and glycogen phosphorylase kinase. PPP1R3A binds both to the PP1 catalytic subunit and to glycogen, forming part of a heterodimeric complex central to glycogen synthesis and degradation. By integrating signaling pathways including those mediated by insulin and adrenaline, PPP1R3A critically modulates energy homeostasis, with genetic variants or altered expression implicated in diseases like type 2 diabetes, obesity, and cardiac arrhythmias. Recent evidence also identifies PPP1R3A as a modulator of calcium handling complexes important for cardiac function, contributing to arrhythmogenic susceptibility when its function is impaired.
Drugs would act by modulating glycogen metabolism or influencing PP1 targeting/activity via PPP1R3A’s regulatory impact (no direct drugs currently listed)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 3A (PPP1R3A).